LXEO

LXEO Operating Expenses

$94.57MTTM · USD

Period ending:

LXEO FY Operating ExpensesUSD
LXEO FY Operating Expenses2020-12-31: $5.11M2021-12-31: $52.29M2022-12-31: $61.16M2023-12-31: $68.51M2024-12-31: $105.77M2025-12-31: $109.26M$109.26M$0.00
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
109,257,000
105,766,000
68,513,000
61,163,000
52,294,000
5,106,264

Compare operating expenses

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.